These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
426 related articles for article (PubMed ID: 2566387)
1. Inhibitory effects of anti-CD2 monoclonal antibodies on interleukin 2 production and interleukin 2 receptor expression in anti-CD3-induced T cell activation. Stohl W; Linker-Israeli M Cell Immunol; 1989 May; 120(2):351-65. PubMed ID: 2566387 [TBL] [Abstract][Full Text] [Related]
2. Inhibition by anti-CD2 monoclonal antibodies of anti-CD3-induced T cell-dependent B cell activation. Stohl W; Crow MK Cell Immunol; 1990 Oct; 130(2):257-70. PubMed ID: 1976440 [TBL] [Abstract][Full Text] [Related]
3. Role of interleukin 2 receptor beta chain in initiating anti-CD3 and interleukin 2-induced proliferation of human resting T cells. Moiré N; Calvo CF; Métivier D; Perrot JY; Vaquero C; Hatakeyama M; Senik A Eur J Immunol; 1990 Sep; 20(9):1981-7. PubMed ID: 2145171 [TBL] [Abstract][Full Text] [Related]
4. The required interaction between monocytes and peripheral blood T lymphocytes (T-PBL) upon activation via CD2 or CD3. Role of HLA class I molecules from accessory cells and the differential response of T-PBL subsets. Huet S; Boumsell L; Dausset J; Degos L; Bernard A Eur J Immunol; 1988 Aug; 18(8):1187-94. PubMed ID: 2901355 [TBL] [Abstract][Full Text] [Related]
5. Human T cell activation: differential response to anti-CD28 as compared to anti-CD3 monoclonal antibodies. Bjorndahl JM; Sung SS; Hansen JA; Fu SM Eur J Immunol; 1989 May; 19(5):881-7. PubMed ID: 2544432 [TBL] [Abstract][Full Text] [Related]
6. Signals involved in T cell activation. T cell proliferation induced through the synergistic action of anti-CD28 and anti-CD2 monoclonal antibodies. Van Lier RA; Brouwer M; Aarden LA Eur J Immunol; 1988 Jan; 18(1):167-72. PubMed ID: 3126073 [TBL] [Abstract][Full Text] [Related]
7. Regulation by anti-CD2 monoclonal antibody of the activation of a human T cell clone induced by anti-CD3 or anti-T cell receptor antibodies. Yssel H; Aubry JP; de Waal Malefijt R; de Vries JE; Spits H J Immunol; 1987 Nov; 139(9):2850-5. PubMed ID: 2444643 [TBL] [Abstract][Full Text] [Related]
8. Activation of cord T lymphocytes. I. Evidence for a defective T cell mitogenesis induced through the CD2 molecule. Gerli R; Bertotto A; Crupi S; Arcangeli C; Marinelli I; Spinozzi F; Cernetti C; Angelella P; Rambotti P J Immunol; 1989 Apr; 142(8):2583-9. PubMed ID: 2564856 [TBL] [Abstract][Full Text] [Related]
9. Regulation of expression of interleukin 2 receptors upon triggering of the TCR-CD3 complex on human T lymphocytes. Kabouridis PS; Tsoukas CD Immunol Invest; 1990 Aug; 19(4):385-401. PubMed ID: 2145219 [TBL] [Abstract][Full Text] [Related]
10. A novel model for antigen-dependent activation of normal human T cells. Transmembrane signaling by crosslinkage of the CD3/T cell receptor-alpha/beta complex with the cluster determinant 2 antigen. Suthanthiran M J Exp Med; 1990 Jun; 171(6):1965-79. PubMed ID: 1972176 [TBL] [Abstract][Full Text] [Related]
11. Activation of peripheral CD8+ T lymphocytes via CD28 plus CD2: evidence for IL-2 gene transcription mediated by CD28 activation. Carabasi MH; DiSanto JP; Yang SY; Dupont B Tissue Antigens; 1991 Jan; 37(1):26-32. PubMed ID: 1676547 [TBL] [Abstract][Full Text] [Related]
12. Differential immunomodulation by anti-CD2 monoclonal antibodies of anti-CD3-induced T cell activation: dependence upon the individual anti-CD3 monoclonal antibody used for activation. Stohl W; Posnett DN; Chiorazzi N Cell Immunol; 1988 Oct; 116(1):73-85. PubMed ID: 2458845 [TBL] [Abstract][Full Text] [Related]
13. Human T-cell leukemia virus type I-induced proliferation of human immature CD2+CD3- thymocytes. Maguer V; Cassé-Ripoll H; Gazzolo L; Dodon MD J Virol; 1993 Sep; 67(9):5529-37. PubMed ID: 8102412 [TBL] [Abstract][Full Text] [Related]
14. Different mechanisms of activation of proliferating CD3+ cells in patients with lymphoproliferative disease of granular lymphocytes. Zambello R; Cassatella MA; Trentin L; Bulian P; Siviero F; Feruglio C; Agostini C; Vespignani M; Chisesi T; Pizzolo G Leukemia; 1991 Nov; 5(11):942-50. PubMed ID: 1835747 [TBL] [Abstract][Full Text] [Related]
15. Role in T-cell activation for HLA class I molecules from accessory cells: further distinction between activation signals delivered to T cells via CD2 and CD3 molecules. Huet S; Boumsell L; Raynal B; Degos L; Dausset J; Bernard A Proc Natl Acad Sci U S A; 1987 Oct; 84(20):7222-6. PubMed ID: 3118361 [TBL] [Abstract][Full Text] [Related]
16. T-cells infiltrating renal cell carcinoma display a poor proliferative response even though they can produce interleukin 2 and express interleukin 2 receptors. Alexander JP; Kudoh S; Melsop KA; Hamilton TA; Edinger MG; Tubbs RR; Sica D; Tuason L; Klein E; Bukowski RM Cancer Res; 1993 Mar; 53(6):1380-7. PubMed ID: 8443817 [TBL] [Abstract][Full Text] [Related]
17. Increased cAMP and cAMP-dependent protein kinase activity mediate anti-CD2 induced suppression of anti-CD3-driven interleukin-2 production and CD25 expression. Lin J; Gettys TW; Qin L; Chavin KD; Yang Q; Ding Y; Punch JD; Bromberg JS Pathobiology; 1995; 63(4):175-87. PubMed ID: 8866788 [TBL] [Abstract][Full Text] [Related]
18. Defect of CD2- and CD3-mediated activation pathways in T cells of atopic patients: role of interleukin 2. Romano MF; Valerio G; Turco MC; Spadaro G; Venuta S; Formisano S Cell Immunol; 1992 Jan; 139(1):91-7. PubMed ID: 1345897 [TBL] [Abstract][Full Text] [Related]
19. Stimulation via the CD3 and CD28 molecules induces responsiveness to IL-4 in CD4+CD29+CD45R- memory T lymphocytes. Damle NK; Doyle LV J Immunol; 1989 Sep; 143(6):1761-7. PubMed ID: 2570801 [TBL] [Abstract][Full Text] [Related]
20. Activation of human T lymphocytes by crosslinking of anti-CD3 monoclonal antibodies. Dixon JF; Law JL; Favero JJ J Leukoc Biol; 1989 Sep; 46(3):214-20. PubMed ID: 2788205 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]